Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Study Night	STARTED	Tiagabine First, Placebo Second	9
First Study Night	STARTED	Placebo First, Tiagabine Second	9
First Study Night	COMPLETED	Tiagabine First, Placebo Second	9
First Study Night	COMPLETED	Placebo First, Tiagabine Second	9
First Study Night	NOT COMPLETED	Tiagabine First, Placebo Second	0
First Study Night	NOT COMPLETED	Placebo First, Tiagabine Second	0
Second Study Night	STARTED	Tiagabine First, Placebo Second	9
Second Study Night	STARTED	Placebo First, Tiagabine Second	7
Second Study Night	COMPLETED	Tiagabine First, Placebo Second	9
Second Study Night	COMPLETED	Placebo First, Tiagabine Second	7
Second Study Night	NOT COMPLETED	Tiagabine First, Placebo Second	0
Second Study Night	NOT COMPLETED	Placebo First, Tiagabine Second	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02387710/flow